Divergent patterns of telomere maintenance mechanisms among human sarcomas: Sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas

被引:71
作者
Ulaner, GA
Hoffman, AR
Otero, J
Huang, HY
Zhao, ZQ
Mazumdar, M
Gorlick, R
Meyers, P
Healey, JH
Ladanyi, M
机构
[1] VA Palo Alto Hlth Care Syst, Med Serv, Palo Alto, CA 94304 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[3] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[6] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA
[7] Mem Sloan Kettering Canc Ctr, Dept Orthopaed Surg, New York, NY 10021 USA
关键词
D O I
10.1002/gcc.20074
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Two types of telomere maintenance mechanisms (TMMs) have been described in human tumors: telomerase activation and alternative lengthening of telomeres (ALT). Although the vast majority of epithelial tumors rely on telomerase activation, many mesenchymal tumors rely on ALT for telomere maintenance, but within this tumor group, the TMMs used by translocation-associated sarcomas have not been systematically studied. We studied telomere lengths and telomerase expression and activity in 30 uncultured tumor samples and in 10 cell lines of Ewing's sarcoma, a prototypical translocation-associated sarcoma, and compared the data to an identical analysis of 60 osteosarcomas, the most common type of sarcoma lacking a specific translocation. Telomerase activity was demonstrated in 21 Ewing's sarcoma tumor samples (70%) and in 9 of 10 Ewing's sarcoma cell lines. Evidence of ALT, indicated by the presence of long and heterogeneous telomeres, was observed only in the cell line without telomerase activity and in none of the 30 Ewing's sarcoma tumor samples. The 9 Ewing's sarcoma patients whose tumors lacked detectable telomerase activity did not differ significantly from the remaining patients in age, stage, EWSR1-FLI1 fusion type, prevalence of TP53 point mutations, or overall survival. The low prevalence of ALT in Ewing's sarcoma contrasted sharply with our data on TMMs in 60 osteosarcomas, which showed ALT in 38 of 60 cases (P < 0.0001). The present study, together with emerging published data on other sarcoma types, suggests that a predominance of telomerase activation in the absence of ALT may characterize sarcomas with specific chromosomal translocations (such as Ewing's sarcoma), whereas a high prevalence of ALT appears typical of sarcomas with nonspecific complex karyotypes (such as osteosarcoma). (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:155 / 162
页数:8
相关论文
共 42 条
[21]   Connecting chromosomes, crisis, and cancer [J].
Maser, RS ;
DePinho, RA .
SCIENCE, 2002, 297 (5581) :565-569
[22]   Telomerase maintains telomere structure in normal human cells [J].
Masutomi, K ;
Yu, EY ;
Khurts, S ;
Ben-Porath, I ;
Currier, JL ;
Metz, GB ;
Brooks, MW ;
Kaneko, S ;
Murakami, S ;
DeCaprio, JA ;
Weinberg, RA ;
Stewart, SA ;
Hahn, WC .
CELL, 2003, 114 (02) :241-253
[23]   Telomerase activity and telomere length in thyroid neoplasia: biological and clinical implications [J].
Matthews, P ;
Jones, CJ ;
Skinner, J ;
Haughton, M ;
de Micco, C ;
Wynford-Thomas, D .
JOURNAL OF PATHOLOGY, 2001, 194 (02) :183-193
[24]   Recurrent chromosome aberrations in cancer [J].
Mitelman, F .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2000, 462 (2-3) :247-253
[25]   Telomere lengths of translocation-associated and nontranslocation-associated sarcomas differ dramatically [J].
Montgomery, E ;
Argani, P ;
Hicks, JL ;
DeMarzo, AM ;
Meeker, AK .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (05) :1523-1529
[26]  
Montgomery E., 2003, Modern Pathology, V16, p17A
[27]   Association between telomerase activity and outcome in patients with nonmetastatic Ewing family of tumors [J].
Ohali, A ;
Avigad, S ;
Cohen, IJ ;
Meller, I ;
Kollender, Y ;
Issakov, J ;
Gelernter, I ;
Goshen, Y ;
Yaniv, I ;
Zaizov, R .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (20) :3836-3843
[28]   Telomere lengthening in telomerase-negative cells: the ends are coming together [J].
Scheel, C ;
Poremba, C .
VIRCHOWS ARCHIV, 2002, 440 (06) :573-582
[29]   Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas [J].
Scheel, C ;
Schaefer, KL ;
Jauch, A ;
Keller, M ;
Wai, D ;
Brinkschmidt, C ;
van Valen, F ;
Boecker, W ;
Dockhorn-Dworniczak, B ;
Poremba, C .
ONCOGENE, 2001, 20 (29) :3835-3844
[30]   Elevated telomerase activity, c-MYC-, and hTERT mRNA expression:: association with tumour progression in malignant lipomatous tumours [J].
Schneider-Stock, R ;
Boltze, C ;
Jäger, V ;
Epplen, J ;
Landt, F ;
Peters, B ;
Rys, J ;
Roessner, A .
JOURNAL OF PATHOLOGY, 2003, 199 (04) :517-525